[Federal Register Volume 69, Number 48 (Thursday, March 11, 2004)]
[Notices]
[Pages 11651-11652]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-5472]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated November 14, 2003 and published in the Federal 
Register on December 2, 2003, (68 FR 67473), Abbott Laboratories, 1776 
North Centennial Drive, McPherson, Kansas 67460-1247, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as an importer of Remifentanil (9739), a basic class of 
controlled substance listed in Schedule II.
    The film plans to import the remifentanil to manufacture a 
controlled substance for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Abbott Laboratories to import the 
listed controlled substance is

[[Page 11652]]

consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971, at this time. DEA has investigated Abbott Laboratories on 
a regular basis to ensure that the company's continued registration is 
consistent with the public interest. This investigation included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to section 1008(a) of the Controlled Substances Import and Export Act 
and in accordance with Title 21, Code of Federal Regulations, Sec.  
1301.34, the above firm is granted registration as an importer of the 
basic class of controlled substance listed above.

    Dated: March 3, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-5472 Filed 3-10-04; 8:45 am]
BILLING CODE 4410-09-M